News

Pfizer Q2: Dividends Speak Louder Than EPS
At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate PFE stock a Sell.
Pfizer beats in Q2 earnings, reaffirms 2025 outlook
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.
Pfizer: Q2 Earnings Snapshot
The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.
Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsAamir Malik - Corporate ParticipantAlbert Bourla
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth
Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.
Pfizer Stock Pops on Q2 Beat-and-Raise
Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast
Pfizer lifts 2025 profit forecast after strong Q2 beats, shares rise
Pfizer (NYSE:PFE) raised its full-year earnings outlook on Tuesday after reporting second-quarter results that surpassed Wall Street expectations, driving its shares up more than 3% in premarket trading.
1 Reason to Buy Pfizer (PFE) Stock
One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's ...
Buy Pfizer Stock At $24?
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Final Trade: PFE, SNV, PLTR & VLO
The final trades of the day with CNBC’s Mike Santoli and the “Fast Money” traders. Ozzy Osbourne’s cause of death revealed ...
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
Had you invested $1,000 into Pfizer's stock on Aug. 1, 2020, your investment would only be worth around $638 as of Aug. 1, ...
Trump Tweets Trigger Stock Swings For Tesla, Boeing, Pfizer—And An Insider Trading Inquiry
Trump tweets trigger major stock swings for companies like Tesla, Boeing, Pfizer. Democrats demand an investigation.
Jim Cramer Warns that Pfizer “Shareholder Base is Getting Very Restive”
Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...
Pfizer raises 2025 profit forecast as cost-cutting program gains traction
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Final Trade: PFE, AFRM, LYFT, AEM
The final trades of the day with CNBC’s Melissa Lee and the "Fast Money" traders. 4 people who have seen the Epstein files ...
Biggest stock movers Tuesday: PFE, PLTR, HIMS, CRSP, and more
Stock futures edged higher on Tuesday as investors weighed a fresh batch of corporate earnings reports alongside comments on ...
Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.